Sunekos 1200

Sunekos

Injectable aesthetic / skin‑booster

Mesotherapy / ECM\u2011regeneration injectable

CE‑marked medical device (Class III) under European medical‑device regulations, as indicated by distributors/vendors. :contentReference[oaicite:26]{index=26}

CE‑marked medical device (Class III) under European medical‑device regulations, as indicated by distributors/vendors. :contentReference[oaicite:26]{index=26}

Mesotherapy / ECM\u2011regeneration injectable

Description

Sunekos 1200 is a mesotherapy‑grade injectable skin booster from Sunekos / Professional Dietetics, combining medium‑/high‑molecular‑weight hyaluronic acid with a proprietary amino acid complex (HY6AA). It is designed to stimulate fibroblasts to produce new collagen and elastin, thereby promoting extracellular matrix (ECM) regeneration. The treatment aims to restore skin volume, improve elasticity, reduce deep wrinkles, enhance hydration, and provide antioxidant protection — particularly useful for mature or damaged skin needing structural support rather than just superficial hydration or filler volume. :contentReference[oaicite:0]{index=0}

Bnefits

Stimulates collagen and elastin production via fibroblast activation (ECM regeneration) :contentReference[oaicite:1]{index=1}
Improves skin hydration and elasticity, reducing sagging and improving firmness :contentReference[oaicite:2]{index=2}
Volumizing effect to address volume loss and skin laxity in mature skin :contentReference[oaicite:3]{index=3}
Antioxidant properties, helping protect skin from oxidative stress and environmental damage :contentReference[oaicite:4]{index=4}
Provides structural skin support (scaffold effect), better suited for deeper wrinkles and advanced signs of skin aging than low‑molecular‑weight HA alone :contentReference[oaicite:5]{index=5}

Indications

Severe wrinkles and deep facial lines in mature or aged skin :contentReference[oaicite:6]{index=6}
Skin volume loss, sagging skin, decreased skin elasticity and tone (face, neck, décolletage, hands, etc.) :contentReference[oaicite:7]{index=7}
Skin quality improvement for damaged or photoaged skin needing ECM regeneration rather than simple superficial hydration :contentReference[oaicite:8]{index=8}
Use as a volumizing ‘scaffold’ in combination protocols (e.g. with other formulations of the brand) for comprehensive rejuvenation :contentReference[oaicite:9]{index=9}

Composition

Medium/high molecular weight hyaluronic acid (≈ 1.2 million Dalton) at ≈ 10 mg/ml :contentReference[oaicite:10]{index=10}
Amino‑acid complex (HY6AA) — a blend of Glycine, L‑Proline, L‑Leucine, L‑Lysine, L‑Valine, L‑Alanine (total ~100 mg per standard pack) :contentReference[oaicite:11]{index=11}

Formulation

Injectable solution / skin‑booster prepared for intradermal / mesotherapy injections. :contentReference[oaicite:12]{index=12}
Pack contains two vials of 1.5 ml each (2 × 1.5 ml) per treatment pack. :contentReference[oaicite:13]{index=13}

Packaging

2 vials × 1.5 ml each per box (total 3.0 ml) for injectable use. :contentReference[oaicite:14]{index=14}

Usage

Must be administered by a qualified medical professional trained in mesotherapy or aesthetic injection techniques. :contentReference[oaicite:15]{index=15}
Injected into mid‑deep dermis (or appropriate layer depending on area) using micro‑bolus or linear threading / cannula techniques. :contentReference[oaicite:16]{index=16}
Recommended treatment protocol: often combined with other treatments / follow‑up depending on skin condition — typically 1–4 sessions. :contentReference[oaicite:17]{index=17}

Contraindications

Known hypersensitivity to hyaluronic acid or any component of the formulation (e.g. amino acids) — standard for HA‑based injectables. (common practice; specific official contraindications not publicly detailed)
Active skin inflammation, infections or compromised skin integrity at injection site — generally advised against by aesthetic providers. :contentReference[oaicite:20]{index=20}
Use in pregnant or breastfeeding women — many aesthetic clinics advise caution / avoid (safety not established) :contentReference[oaicite:21]{index=21}

Adverse Effects

Transient redness, swelling, mild bruising or tenderness at injection site — commonly reported. :contentReference[oaicite:22]{index=22}
Possible temporary bumps or mild nodularity immediately post-injection, typically resolving within 24–48 h. :contentReference[oaicite:23]{index=23}

Storage Conditions

Store unopened vials per manufacturer instructions — cool, dry environment; avoid extreme heat or freezing. (Standard for injectable HA-based products; vendors specify storage accordingly) :contentReference[oaicite:24]{index=24}
Use immediately after aseptic reconstitution; do not store reconstituted product. (Standard procedural requirement for sterility) :contentReference[oaicite:25]{index=25}

Duration

Not strictly defined \u2014 protocol often involves 1 to 4 treatments (depending on skin condition), with maintenance sessions every 3\u20134 months or as advised by clinician. :contentReference[oaicite:18]{index=18}

Onset

Often initial improvement (hydration/volume) visible immediately post\u2011treatment; structural benefits (improved elasticity, skin firmness) typically emerge over subsequent weeks. :contentReference[oaicite:19]{index=19}